Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Free Cash Flow Generation Index
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of CN¥71.38 Million represents 1% of operating cash flow (CN¥76.07 Million). See 688621 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing Sun Novo Pharmaceutical Research Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Beijing Sun Novo Pharmaceutical Research Co Ltd across 8 annual periods. Explore how well can Beijing Sun Novo Pharmaceutical Research service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for Beijing Sun Novo Pharmaceutical Research Co Ltd. For the full company profile including market capitalisation, see market value of Beijing Sun Novo Pharmaceutical Research.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.05x | CN¥1.54 Million | CN¥32.02 Million | CN¥30.48 Million | ▼ -77.6% |
| 2023 | 0.21x | CN¥19.90 Million | CN¥92.86 Million | CN¥72.96 Million | ▲ +24139.9% |
| 2022 | 0.00x | CN¥91.92K | CN¥103.96 Million | CN¥103.87 Million | ▼ -97.6% |
| 2021 | 0.04x | CN¥3.29 Million | CN¥88.25 Million | CN¥84.96 Million | ▼ -93.5% |
| 2020 | 0.57x | CN¥35.96 Million | CN¥62.99 Million | CN¥27.03 Million | ▲ +3.9% |
| 2019 | 0.55x | CN¥31.30 Million | CN¥56.97 Million | CN¥25.67 Million | ▼ -12.5% |
| 2018 | 0.63x | CN¥27.70 Million | CN¥44.11 Million | CN¥16.41 Million | ▲ +138.9% |
| 2017 | -1.62x | CN¥-12.94 Million | CN¥8.01 Million | CN¥20.96 Million | — |